Search
for
Sort by
Research 391–420 of 1000+
- How to treat androgenetic alopecia – the most common form of hair loss. A review
- Bioinspired engineering ADSC nanovesicles thermosensitive hydrogel enhance autophagy of dermal papilla cells for androgenetic alopecia treatment
- Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
- Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Sustainability of functional hair follicle activity: Impact of spatially anchored multifunctional tetrahedral framework nucleic acids
- Therapeutic potential of stem cell-derived exosomes in hair regeneration: A systematic review
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- Clascoterone: a new topical antiandrogen agent.
- IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
- Finasteride and Dutasteride for the Treatment of Male Androgenetic Alopecia: A Review of Efficacy and Reproductive Adverse Effects
- The Potential of Moringa (Moringa oleifera Lamk) Seed Oil as Anti- Alopecia
- The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice
- Testosterone’s regulation of the HPA axis differs for adolescent and adult male rats
- DIABETE E DOLORE: EFFETTO TERAPEUTICO DEI METABOLITI DEL TESTOSTERONE
- Comment on Malloy (2008) “James Watson tells the inconvenient truth: Faces the consequences”
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- 5α-Reductase Inhibitors in the Treatment of Androgenetic Alopecia
- The human skin as a hormone target and an endocrine gland
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase
- Steroidogenesis of the testis – new genes and pathways
- The Hair Follicle: A Paradoxical Androgen Target Organ
- Finasteride in the treatment of alopecia
- C<sub>19</sub>and C<sub>21</sub>5<i>β</i>/5<i>α</i>Metabolite Ratios in Subjects Treated with the 5<i>α</i>-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5<i>α</i>-Reductase Deficiency*
- The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency.